Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan.
Ryuta UrakawaEmiko Tanaka IsomuraKazuhide MatsunagaKazumi KubotaPublished in: Vaccines (2022)
Young, female, and having no comorbidities are risk factors for AEs after the third dose of BNT162b2, while vaccination interval is not.